“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

Dr. Buse has spent a career documenting what it looks like to live in this reality. Her work with the American Migraine ...

Teva Pharmaceutical has reported the final analysis of the PEARL Phase IV migraine prevention trial of the anti-calcitonin ...

Considering direct medical expenses and lost productivity, migraines are responsible for $78 billion in annual costs in the ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than half of those treated for chronic migraine who responded during the first ...

The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance ...

Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...

Qasim Amin Nathari is on a mission to change the narrative around Chronic Migraine, particularly for Black men in America.

The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance ...